Menu

Recent Interviews

Matthew Salthouse, CEO, Kainantu Resources

Matthew Salthouse
CEO | Kainantu Resources
3 Phillip Street #19-01 Royal Group Building, 048693 Singapore (SGP)

info@krl.com.sg

+65 6920 2020

Interview Kainantu Resources: "We hold the key to growth in the Asia-Pacific region".


Justin Reid, President and CEO, Troilus Gold Corp.

Justin Reid
President and CEO | Troilus Gold Corp.
36 Lombard Street, Floor 4, M5C 2X3 Toronto, Ontario (CAN)

info@troilusgold.com

+1 (647) 276-0050

Interview Troilus Gold: "We are convinced that Troilus is more than just a mine".


John Jeffrey, CEO, Saturn Oil + Gas Inc.

John Jeffrey
CEO | Saturn Oil + Gas Inc.
Suite 1000 - 207 9 Ave SW, T2P 1K3 Calgary (CAN)

info@saturnoil.com

+1-587-392-7900

Saturn Oil + Gas CEO John Jeffrey: "Acquisition has increased production by 2,000%"


14. December 2020 | 12:37 CET

BYD, Almonty Industries, Alexion - Take advantage of the correction!

  • Investments
Photo credits: pixabay.com

It is here, the second hard lockdown due to the global Corona pandemic. After the broad market in the past few days announced a correction, there are again numerous opportunities to get more favorable stocks of great interest. Even sectors that have risen disproportionately, such as electromobility, hydrogen and e-commerce, are heading south—a new opportunity to bet on the winners of the future.

time to read: 3 minutes by Stefan Feulner
ISIN: CA0203981034 , CNE100000296 , US0153511094


 

Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author


Clear target in sight

Unimpressed by the news of the past few days, the Canadian Company Almonty Industries is pursuing its goal of building the world's largest tungsten mine in Sangdong, South Korea. This mine would then produce 5% of the world's tungsten production and cover 30% of production outside China. The final contract with KfW-IPEX Bank was signed last week. The project financing is worth USD 75.1 million. A buyer for the tungsten concentrates, which are to be produced in Sangdong from 2022, has already been found. It is the Austrian Plansee Group, which is also providing EUR 30 million in bank guarantees to mitigate potential cost overruns.

Confidence-building measures

The fact that a long, trusting partnership is emerging here is reflected in the shareholder book. The Plansee Group takes over shares from the Company's CEO, making it the main shareholder. Deutsche Rohstoff AG remains on board with a current stake of 12.8%. Analyst Simon Scholes of First Equity Research celebrates this deal with a "buy" rating. His target price is CAD 1.45. Currently, Almonty's share price is at CAD 0.66, a potential doubling opportunity!

Vaccine candidate with record acquisition

AstraZeneca is still well in the global race for approval of a vaccine against the Coronavirus. Although the British Company has been left behind in the timetable by its competitors Moderna and the joint venture between BioNtech and Pfizer, a marketing authorization application could still be submitted within the next six weeks if the results of the trials are positive. Now the British pharmaceutical giant, formed in 1999 from the merger of Sweden's Astra with Britain's Zeneca, is looking to expand its portfolio.

Record acquisition to expand

The purchase of the US biotech Company Alexion is worth a whopping USD 39.0 billion to the British Company. In the process, AstraZeneca intends to pay a total of USD 175 per Alexion share in cash as well as in its own securities. With the acquisition, AstraZeneca aims to expand its immunology and rare diseases business. In 2019, Alexion generated sales of just under USD 5.0 billion in this division. The lion's share of this is accounted for by the drug Soliris. This drug is used to treat paroxysmal nocturnal hemoglobinuria, a rare, life-threatening disease that leads to the destruction of red blood cells. Currently, the British themselves have a stock market value of EUR 115.99 billion. The expansion of the product range makes sense, and the acquisition target promises great potential. Moreover, the British are still lagging in vaccine development. However, the demand will be so great that enormous sales can still be generated upon approval.

Strong figures confirm the trend

The electric car manufacturer BYD continues to deliver strong delivery figures. In November 2020, for example, a total of 53,943 vehicles were delivered to customers, more than 6,200 more than in the previous month. The main sales driver here was, of course, the New Energy Vehicle segment, which consists primarily of hybrid and all-electric vehicles. With 26,690 units, the Chinese recorded a healthy increase of well over 200% compared with the same period last year, when only 11,220 units were sold. By contrast, sales of cars with internal combustion engines fell by 9.4%.

Share too expensive

Arguing that the stock was overvalued, analysts at asset manager UBS lowered the stock from "neutral" to "sell." The "Build your dreams" share has received some advance praise in recent months, which is reflected in the significantly increased share price. Currently, the share price, which reached its high at EUR 22.39, is going through a first correction phase. At EUR 18.20, there is a broad support zone that has already been successfully defended once. The 50-day line is now also located in this area. If this zone holds, BYD could soon head north again.


Author

Stefan Feulner

The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
He is passionate about analyzing a wide variety of business models and investigating new trends.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

29. July 2021 | 13:56 CET | by André Will-Laudien

Alibaba, Memiontec, MorphoSys - Now the rally after the sell-off!

  • Investments

The regulator's pressure is getting bigger and bigger. China has tightened the thumbscrews on technology giants and especially their online education companies - triggering a stock market quake on its own stock market. In some cases, well-known tech stocks lost double digits, even though the affected areas only affect fractions of annual sales. Government regulation of the USD 100 billion-plus education market is likely to weaken confidence in China's stock markets for the long term. And the fact that China's trade relations with the US have also reached a low point does not make things any better. Are there still opportunities?

Read

28. July 2021 | 10:14 CET | by Nico Popp

Barrick Gold, Mineworx, TUI: Summertime is investment time

  • Investments

Invest or consume? Given the difficult months many of us have had, it would be understandable to unwind now: sun, beach and sea beckon despite rising numbers. But it may also make sense to think more long-term in the face of rapid change. Central banks are allowing more inflation and the printing press continues to run fast. Especially in the current summer lethargy, this can be an opportunity for people with foresight.

Read

26. July 2021 | 12:18 CET | by Stefan Feulner

Twitter, wallstreet:online, Snap - Rally or Crash?

  • Investments

What is next for the global stock markets? Several experts are already passing around price targets of 20,000 points for the DAX due to a lack of investment alternatives. At the same time, the bear camp sees the bursting of the bubble, which was created by the massive financial injections of the FED, coming our way as early as this summer and predicts a crash of unimagined proportions.

Read